Get the Daily Brief
Latest Biotech News
Biomanufacturing Innovation: Repligen and Univercells Integrate Real-Time Monitoring
Repligen and Univercells Technologies have partnered to embed real-time glucose and lactate monitoring within Univercells' scale-X bioreactors. The integration of Repligen’s MAVEN platform enables...
Capricor Cell Therapy Faces FDA Setback for Duchenne Muscular Dystrophy
Capricor Therapeutics received a Complete Response Letter (CRL) from the FDA regarding its deramiocel cell therapy for cardiomyopathy in Duchenne muscular dystrophy (DMD). The agency cited...
Merck Acquires Verona Pharma in $10 Billion COPD Expansion
Merck & Co. completed a $10 billion acquisition of Verona Pharma, expanding its portfolio with a fast-growing COPD treatment. The deal focuses on leveraging Verona’s lead drug, Ohtuvayre, and its...
Advanced AI Models Accelerate Protein and Genomic Research
New AI-driven technologies demonstrate significant strides in molecular biology. Microsoft's BioEmu generative deep learning model rapidly predicts protein dynamics, enabling large-scale...
Biomanufacturing Talent Crunch Looms by 2028, Experts Warn
Jason Beckwith, PhD, highlights a looming 'talent singularity' in biomanufacturing by 2028, where skilled labor demand will surpass supply due to technological advances and insufficient...
Intranasal Monoclonal Antibody Shows Promise Against Hay Fever and Asthma
Researchers at Kazakh National Agrarian Research University engineered a monoclonal antibody administered intranasally that prevents pollen-induced hay fever and asthma symptoms in mice sensitized...
Emerging Therapeutics: Circular RNA Drug Candidate and ADPKD Start-Up Launch
Shanghai Circode Biomed is initiating clinical trials for HM-2002, a circRNA-based therapeutic for ischemic heart disease with regulatory clearances in China and the US. Separately, Renasant Bio...
FDA Greenlights Cochlear’s Smart Implant and Seeks Transparency in Drug Reviews
The FDA approved Cochlear Ltd.’s Nucleus Nexa System, the first smart cochlear implant expected to launch imminently in the US, enhancing auditory device capabilities. Concurrently, FDA...
Biopharma Deal Surge: $35 Billion in June Drives 2025 Market Momentum
Biopharma dealmaking hit $35.07 billion in June 2025, marking the highest monthly total this year and contributing to a $138.31 billion first-half total surpassing previous years' full totals....
Amyloid Proteins Are Just the Beginning: New Study Finds 200+ Misfolded Proteins Linked to Cognitive Decline
Johns Hopkins researchers employed limited proteolysis mass spectrometry to uncover over 200 types of misfolded proteins in aged rat brains associated with cognitive decline. Their findings,...
Real-Time Monitoring Enhances Viral Vector and Vaccine Manufacturing: Repligen-Univercells Partnership
Univercells Technologies and Repligen announced a collaboration to incorporate Repligen’s MAVEN® Real Time Glucose Control Platform into Univercells’ scale-X bioreactors. This integration enables...
Capricor’s Duchenne Cell Therapy Faces FDA Setback: Complete Response Letter Cites Data Gaps
Capricor Therapeutics received a Complete Response Letter from the FDA rejecting the Biologics License Application for deramiocel, a cell therapy for cardiomyopathy in Duchenne muscular dystrophy...
Merck Acquires Verona Pharma for $10 Billion: Strategic Bet on Pulmonary Disease Portfolio
Merck & Co. closed a $10 billion acquisition of Verona Pharma, adding a fast-growing COPD candidate to its cardio-pulmonary disease pipeline. The deal hinges on Verona’s lung drug patent...
AI Accelerates Protein Dynamics Modeling: Microsoft Research Introduces BioEmu System
Microsoft Research unveiled BioEmu, a generative deep learning model that rapidly simulates protein equilibrium ensembles with remarkable speed and accuracy. Published in Science, BioEmu can...
New Antibody Mapping Chip Speeds Vaccine Research: Scripps Scientists Reveal Hidden Viral Binding Sites
Researchers at Scripps Research developed a microchip capable of rapidly mapping how human antibodies bind to viruses from a single drop of blood. This novel technology provides faster, clearer...
Jazz Pharma Names Renee Gala as New CEO Amid Ongoing Pipeline Developments
Jazz Pharmaceuticals announced it will appoint Renee Gala as CEO, succeeding the retiring Bruce Cozadd. Gala currently serves as Chief Operating Officer. The leadership change occurs during active...
Biomanufacturing Faces Talent Shortage by 2028: Industry Experts Advocate Upskilling and Cross-Recruitment
Industry analysis forecasts a significant talent deficit in biomanufacturing by 2028, driven by evolving technological demands and insufficient pipeline of skilled workers. Jason Beckwith, PhD,...
FDA Approves Cochlear Ltd’s Next-Gen Smart Implant: Nucleus Nexa System Cleared for Launch
The U.S. FDA granted approval to Cochlear Ltd’s Nucleus Nexa System, the first smart cochlear implant incorporating advanced technology for hearing restoration. Anticipated for U.S. launch within...
Intranasal Monoclonal Antibody Halts Allergy and Asthma Symptoms in Proof-of-Concept Mouse Study
Scientists at Kazakh National Agrarian Research University engineered a monoclonal antibody targeting mugwort pollen allergen, delivered intranasally to mice, preventing allergic rhinitis and...
Merck’s $10B Bet on Verona Pharma’s Lung Drug Patents
Merck & Co. completed a $10 billion acquisition of Verona Pharma, aiming to strengthen its portfolio in cardio-pulmonary diseases with Verona’s COPD drug, Ohtuvayre. Despite the main patent for...